Assessment of the health and the economic burden of haemophilia in Belgium: a rare, very expensive and largely unknown disease with multiple public health challenges Ghent University
Background : Haemophilia is a rare hereditary haemorrhagic disease requiring regular intravenous injections of clotting factor (CF). The aim of this study is to estimate the health and the economic burden of haemophilia in Belgium. This study may also be useful in a global future evaluation of haemophilia since worldwide such a study has never been done. Moreover, the study fits with the growing interest for haemophilia of the Belgian government ...